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Background: Hydatid cyst disease is still a problem in many countries. Surgical removal is currently the generally
accepted choice of treatment for lung hydatidosis. However, operating on bilateral widespread lung hydatidosis is
still controversial. The aim of this retrospective study was to evaluate the results of surgical treatment in bilateral
multiple hydatid disease of the lung.
Methods: In this study, we reviewed our experience in the surgical treatment of 17 (3.7%) patients with bilateral,
and at least three, lung hydatid cysts. These 17 patients (8 male, 9 female), with an average age of 34.6 years (range
12–58 years), underwent bilateral staged thoracotomy.
Results: In total 105 lung cysts were removed from 17 patients who underwent staged thoracotomies. The mean
count of cysts was 6.7 (range 3–20 cysts). Most of the cysts (38.2%) were located in the right lower lobe. The mean
interval between thoracotomies was 4.2 (range 3–5) days. Two patients (11.7%) had cysts associated with hepatic
hydatidosis and one (5.8%) had cysts associated with the spleen; they were treated via phrenotomy during
thoracotomies. All cysts were removed without lung resection. We observed some complications such as
prolonged air leaks (n = 2), atelectasis (n = 3) and empyema (n = 2). No further surgery was required for
management of complications. The mean hospital stay was 9.3 days. (range 7–23 days). Oral albendazole was
started on the 2nd post operative day after the first thoracotomy in the dose of 10–20 mg/kg and was continued
for 3 months with a gap of 1 week after each 21 days. No recurrences or deaths occured during the follow-up
period.
Conclusions: Although staged thoracotomy applied in 3–5 days after the initial thoracotomy increases the total
hospital stay, it decreases the chance of possible complications can occur in cysts in the other lung when long
intervals are preferred between the first and the second thoracotomy. In our experience, bilateral staged
thoracotomy is an appropriate surgical option because morbidity rates are minimal and the hospital stay is
acceptable for the treatment of bilateral widespread lung hydatidosis, even in patients who had a total of 20
hydatid cysts.
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Hydatid disease is still a serious health problem in some
Mediterranean countries, the Middle East, New Zealand,
Australia, South Africa, and South America , where it is
endemic [1,2]. Recently, the prevalence of the disease has
increased in Europe and North America, due to increased
immigration [3]. The lung is the second most commonly
affected organ after the liver, with occurrences ranging* Correspondence: lhasdiraz@erciyes.edu.tr
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reproduction in any medium, provided the orfrom 10 to 40% [1]. Bilateral pulmonary hydatidosis ac-
counts for 4% to 26.7% of all cases of pulmonary
hydatidosis [3,4].
Surgical removal is currently the generally accepted
choice of treatment for lung hydatidosis. Medical treat-
ment is limited with patients who refuse surgical interven-
tion or who are considered to be inoperable. Operating on
bilateral widespread lung hydatidosis is still controversial.
The aim of this retrospective study was to evaluate the re-
sults of surgical treatment in bilateral multiple hydatid dis-
ease of the lung.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Between January 1990 and January 2010, 452 patients
with pulmonary echinococcosis were operated on at
Erciyes University’s Thoracic Surgery Department. Of
the 452 patients, 48 (10.6%) had bilateral lung hydatid
cysts. We retrospectively reviewed the medical records
of 17 (3.7%) patients who had bilateral, and at least
three, lung cysts. None of these patients had intratho-
racic but extrapulmonary located hydatid cysts such as
diagrahmatic, pleural and mediastinal. 17 patients
(8 male, 9 female) with an average age of 34.6 years
(range, 12–58 years) underwent bilateral stage thoracot-
omy. All cases were studied thoroughly before surgery
by means of clinical examination and investigations.
Chest X-ray and computed tomography scan were the
mainstays of diagnosis (Figure 1).
The study protocol was approved by institutional Eth-
ics Committee (No:2013–150).Figure 1 Computed tomography scan demonstrates bilateral multipleAn abdominal ultrasound was performed in all cases
as part of the preoperative evaluation. Baseline haema-
tology, biochemistry, lung function tests and electrocar-
diogram were also carried out routinely in all cases.
Two stage bilateral thoracotomy was carried out under
general anesthesia with double lumen endotracheal
tubes. Muscle-sparing thoracotomies were carried out in
all patients. A second muscle-sparing thoracotomy was
carried out 3–5 days after the first thoracotomy. The
side with the largest cyst or greatest number of cysts
was initially treated. In patients who had an intact cyst
on one side and a ruptured cyst on the other, the intact
cyst was initially operated. All adhesions were totally di-
vided to facilitate exploration and re-expansion of the
lung. The operative field was isolated with 20% hyper-
tonic saline pads for protection. Conservative paren-
chyma preserved surgical techniques were the methods
of choice. While the lung was kept inflated, a 16-Glung cysts.
Table 2 Number of cysts according to location
Patient no: RUL RML RLL LUL LLL Liver Spleen Total
1 - 1 - 1 1 1 - 4
2 1 - 1 - 1 - - 3
3 5 1 6 4 4 1 - 21
4 1 - 1 - 1 - - 3
5 - - 1 2 1 - - 4
6 2 - 5 4 3 - - 14
7 2 - 4 3 4 - 1 14
8 2 - 3 - 1 - - 6
9 - - 1 1 1 - - 3
10 1 - 1 - 1 - - 3
11 2 - 3 - 2 - - 7
12 1 - 2 - 1 - - 4
13 - - 2 1 2 - - 5
14 1 - 2 - 1 - - 4
15 1 - 2 - 1 - - 4
16 1 - 2 1 1 - - 5
17 1 - 2 - 1 - - 4
Total 21 2 38 17 27 2 1 108
RUL: Right upper lobe, RML: Right middle lobe, RLL: Right lower lobe, LUL: Left
upper lobe, LLL: Left lower lobe.
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cyst. After needle aspiration, an antiscolicidal agent
(hypertonic saline 20%) was injected into the cystic cav-
ity. We waited three minutes for deactivation of the
cysts. When the cyst was aspirated and its fluid removed
as completely as possible, the most prominent part of
the cyst was opened (cystotomy) and the cyst membrane
was removed with ring forceps. The cavity was then irri-
gated with saline solution and the bronchial openings
were sutured. The cavity was obliterated with purse-
string sutures of absorbable material, starting from the
bottom (capitonnage) or its modifications. Anatomical
resections were carried out in none of the patients.
Patients with associated hepatic or splenic cysts were
approached through the transthoracic transdiaphragmatic
route.
Patients were extubated on the table and then shifted
to the recovery room. The usual postoperative manage-
ment was carried out including administering adequate
analgesics and antibiotics. Inspiratory exercises were en-
couraged upon the first day following surgery. Chest
drains were removed after cessation of drainage, air leak
and radiological lung expansion.
Oral albendazole was started on the postoperative day
two after the first thoracotomy in the dose of 10–20 mg/kg
and was continued for 3 months with a gap of 1 week after
each 21 days. Liver function parameters were monitored
during the course of albendazole. The patients were
followed up regularly. A chest X-ray was performed at the
end of each year.
Results
The most frequent symptoms were cough, chest pain
and dyspnea (Table 1).A total of 105 lung cysts were re-
moved from the 17 patients who underwent staged
thoracotomies. Most of the cysts (36.1%) were located in




Chest pain 6 (35%)
Dyspnea 5 (29.4%)
Blood-streaked sputum 3 (17.6%)
Haemoptysis 1 (5.8%)
Expectoration of salty sputum hydatid fluid and
fragments of laminated membrane
2 (11.7%)
Hypersensivity reaction symptoms † 2 (11.7%)
Febrile episodes 2 (11.7%)
Mucopurulent sputum 3 (17.6%)
Abdominal pain 2 (11.7%)
†Urticeria, pruritis and bronchospasm.The mean interval between thoracotomies was 4.2
(range 3–5) days. The mean cyst size was 3.8 cm (range
1–10 cm) in diameter. In 3 patients (17.6%), the cysts
were suppurative. 37 of the cysts (35.2%) were perforated
(Figure 2).
Cystotomy with capitonnage was carried out in all pa-
tients except in those with peripherally located small
cysts. Additional surgical procedures such as wedge re-
section, decortication and debridement of necrotic tis-
sues were carried out in 5 patients (29.4%). After
removal of the cysts, the lung tissue was observed to
have completely re-inflated in all patients. Postoperative
complications such as prolonged air leaks, atelectasis
and empyema were observed in 3 of 17 patients
(Table 3). In two patients prolonged air leak and empy-
ema occurred after the second thoracotomy. In empy-
ema cases during surgery it was observed that the cysts
were perforated and spilled into the pleural cavity. These
patients with prolonged air leak and empyema received
conservative medical treatment. In these two patients
atelectasis occurred after the second thoracotomy and
bronchoscopy was required. In one patient, atelectasis
occured at early period of the first thoracotomy. It also
recovered after bronchoscopy. Six cases in our series
were referred to our clinic after failure of medical treat-
ment. Three of them had a lung abscess. In one case, ex-
pansion of the lung could not be achieved so the first
Figure 2 Computed tomographic scan of a 20-year-old male demonstrates bilateral multiple and perforated lung cysts four months
after medical treatment.
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cotomy, was maintained during the second thoracotomy.
No further surgery was required for management of
complications. Associated abdominal hydatidosis was
found in 3 (17.6%) cases. Two patients (11.7%) with cysts
associated with hepatic hydatidosis and one (5.8%) with
cysts associated with spleen were treated via phrenotomy
during thoracotomy. All cysts were removed without
lung resection. The mean hospital stay was 9.3 days.
(range 7–23 days). Patients were restored to their full
working capacity in a short period (2 ± 1 months). Nei-
ther recurrence nor death occurred during the follow-up
period. (1–5 years).
Discussion
The quests for minimally invasive treatment of bilateral
widespread echinococcosis has continued for a long
time. The potential risks involved in surgery may
lead some physicians to prefer medical treatment.
Albendazole is the most commonly used agent [5]. It is
recommended that albendazole treatment should last for
at least 3 months [3,6]. There are numerous side effects
in medical treatment, which can be potentially life-Table 3 Postoperative data of patients
Variable No. of patients (%)
Prolonged air leak 2 (11.7%)
Empyema 2 (11.7%)
Atelectasis 3 (17.6%)
Wound infection 0 (0%)
Mean intensive care unit stay (days)* 1 day
Mean duration of tube thoracostomy (days) 4.7 (range 3–21 days)
Mean hospital stay (days) 9.3 (range 7–23 days)
*All patients were monitored in the intensive care unit in the first
postoperative day.threatening in some cases [7,8]. On the other hand, the
number of cases reported where cysts disappeared as a
result of this treatment is very rare [9]. While the clinical
and radiological response to medical treatment is con-
sidered successful, about half of these cysts were found
to be alive when patients underwent surgery [10]. On
the other hand, although death of the cysts is seen as
proof of the successful medical treatment, it is known
that corrupt germinative membrane in the integrity of
lung parenchyma can cause lung abscess.
Parenchymal sparing surgery is the generally preferred
opinion in surgical treatment of echinococcosis. There is
therefore no difference between removal of a large cyst
or a large number of cysts within the same lobe as
regards parenchymal loss after surgery. Essentially the
idea that “the removal of a large number of cysts causes
a capacity loss in lung parenchyma” is not proven.
In the literature, pulmonary function loss has not been
shown in cases when a large number of cysts were re-
moved from a lung. In our series, although we removed
6 cysts from the same lobe (a total of 20 cysts in both
lungs) we observed that the lung ventilated very well at
the end of the process. No radiological or clinical prob-
lems were seen in the postoperative period. On the other
hand, parenchymal compression will disappear after re-
moval of the cysts thus providing a higher lung volume
than any loss resulting from surgical treatment. No tech-
nical reasons for inoperability, such as cysts location,
were reported in patients who received surgical treat-
ment for widespread lung hydatidosis. Therefore, the
idea that aggressive surgical treatment for widespread
hydatidosis is associated with morbidity is more likely
associated with incision-related problems. Undoubtedly,
the functional and aesthetic loss created by incisions
can’t be ignored. However the effectiveness of medical
treatment is very limited and it has potential side effects.
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tidosis can be afforded for radical surgical treatment to
provide complete eradication of hydatidosis.
The surgical options for patients who have bilateral
lung disease, include bilateral simultaneous thoracoto-
mies (synchronous), bilateral staged thoracotomies sepa-
rated by some time period (metachronous), median
sternotomy and Clamshell incision. Each strategy has
advantages and disadvantages and, like other controver-
sial aspects of the care of these patients, has not been
extensively studied. Probably the most common ap-
proach is staged thoracotomies, which provides optimal
exposure of each hemithorax and avoids the longer op-
erative and anesthetic time associated with synchronous
thoracotomies. A disadvantage of this approach is the
potential for delay between the first and second thora-
cotomies due to slow recovery or postoperative compli-
cations. This may allow progression of disease, making
eventual resection more difficult [11]. Surgical treatment
of pulmonary hydatid cysts may cause potantial compli-
cations especially in patients who have multiple bilateral
lung cysts. Each surgical application has complication
risks for bilateral lungs. The possibility of occurring com-
plications in bilateral lung at the same time can be life
threatening. So simultaneous bilateral lung complications
may increase the mortality rates. Therefore we avoided to
apply bilateral thoracotomies as a single stage.
Two stage thoracotomy and median sternotomy are
the most common approaches in the surgical treatment
of bilateral lung hydatidosis. Single-session surgery via
median sternotomy is a rational intervention for bilateral
lung hydatidosis. It provides high postoperative patient
comfort and shorter duration of hospital stay [12,13].
However, the sine qua non rule in surgical treatment is
to ensure the complete eradication of cysts. Therefore if
some cysts can’t be reached for technical reasons via
median sternotomy, surgical treatment can be unsuc-
cessful. Prolonged air leak, postoperative lung and pleura
infections are more likely to occur in cases of compli-
cated cysts. Therefore, some clinics, including ours’,
prefer two stage thoracotomy in cases in which cysts are
difficult to reach and are complicated [13-15]. A few
days after the first thoracotomy, the second stage thora-
cotomy can be performed after monitoring for surgical
complications and reserves of the lungs to guarantee the
health of the operated lung. We applied the second
thoracotomies after anesthesiologist’s approval. Sevofluran
was choosen for anesthesia because of its rare hepatotox-
icity rate as mentioned in the literature [16].
Pulmonary hydatid cysts also have potentially life
threatining complications such as infection and anaphyl-
axis.Therefore we endeavored not to loose time between
two thoracotomies for patients’ safety. Already the com-
plications occurred in two patients (prolonged air leakand empyema) were probably due to pleural perforation
of pulmonary cysts. In these patients, intact side of cysts
was preferred for the first thoracotomy.
On the other hand, the possibility of associated abdom-
inal hydatidosis is very high in patients with bilateral dif-
fuse cystic disease [4,17]. These diseases can be treated by
adding phrenotomy to thoracotomy. In our series, we
managed to succesfully treat two patients who presented
with hepatic cysts and one patient with splenic cyst via
phrenotomy. Even though we acknowledge that median
sternotomy is a potentially effective approach, we did not
use this approach in our series because it has been
reported in the literature that mediastinal infections after
median sternotomy may have mortal consequences [15].
In our cases we found it sufficient to wait 3–5 days be-
tween the two thoracotomies. We believe that this time
is adequate to observe any complications which may
occur after the first thoracotomy. The complication rate
of our series was 17,6%. In our opinion this relatively
high complication rate was due to pleural perforation
and large size of cysts.
Surgical procedure-related mortality rates have been
reported in the literature as 1–2% [4,18]. These mortality
rates are acceptable, and the recurrence rate is low (1–3%).
In our series, we observed no mortality or recurrence
in the follow up period. (1–5 years).
Limitation of this study is being a retrospective review
including low number of patients. This study requires to
be supported by large-scale prospective evaluations.
Conclusions
Although two stage thoracotomy applied 3–5 days after
the first thoracotomy increases the total hospital stay, it
prevents possible complications that can occur in the
other lung when long intervals are preferred before ap-
plying the second thoracotomy. In addition, it eliminates
the necessity for re-assessment procedures before the
second application because patients have not been
discharged. In our experience, bilateral two stage thora-
cotomy is an appropriate surgical option with acceptable
morbidity rates and duration of hospital stay for treat-
ment of bilateral widespread lung hydatidosis, even in
patients who had a total of 20 hydatid cysts.
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